(18)F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer

BACKGROUND: Prostate Specific Membrane Antigen (PSMA) – positron emission tomography (PET) guides metastasis-directed radiotherapy (MDRT) in prostate cancer (PrCa). However, its value as a treatment response assessment tool after MDRT remains unclear. Importantly, there is limited understanding of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesci, Aruz, Ahmadi, Elham, Ali, Amr, Gouran-Savadkoohi, Mohammad, Evelyn Tsakiridis, Evangelia, Biziotis, Olga-Demetra, Chow, Tom, Kapoor, Anil, Sur, Monalisa, Steinberg, Gregory R., Liu, Stanley, Zukotynski, Katherine, Tsakiridis, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879766/
https://www.ncbi.nlm.nih.gov/pubmed/36713978
http://dx.doi.org/10.1016/j.ctro.2023.100583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879766/
https://www.ncbi.nlm.nih.gov/pubmed/36713978
http://dx.doi.org/10.1016/j.ctro.2023.100583

Ejemplares similares